Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03074201 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP
A NA study of Choledocholithiasis and Biliary Obstruction, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03074201: Completed NA study of Choledocholithiasis and Biliary Obstruction, sponsored by Stanford University.
NCT03074201 is a NA study of Choledocholithiasis and Biliary Obstruction that has completed, run by Stanford University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03074201, a NA study of Choledocholithiasis and Biliary Obstruction, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP for non-complex bile duct stone disease.
Primary Outcome
Successful clearance of stones from the bile duct using cholangioscopy
Conditions Studied
Interventions
- PROCEDURE Cholangioscopy
- DEVICE Spyglass DS Cholangioscope
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-10-01 |
| Est. Completion | 2017-05-20 |
| Phase | NA |
What the finished NCT03074201 record still lists
NCT03074201 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Choledocholithiasis appearing as the primary indexed condition, and to 2 interventions - of which Cholangioscopy is the first listed.
NCT03074201 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03074201 about?
NCT03074201 is a clinical study titled "Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP". Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP for non-complex bile duct stone disease.
What is the current status of trial NCT03074201?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-10-01. Estimated completion is 2017-05-20.
What conditions does trial NCT03074201 study?
This clinical trial studies the following conditions: Choledocholithiasis, Biliary Obstruction.
What interventions are being tested in trial NCT03074201?
The interventions under investigation include: Cholangioscopy (PROCEDURE), Spyglass DS Cholangioscope (DEVICE).
Who is sponsoring clinical trial NCT03074201?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03074201 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Choledocholithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03074201's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI